跳轉至內容
Merck
全部照片(1)

重要文件

QIA88

Millipore

ProteoExtract® 细胞溶胶/线粒体分级分离试剂盒

同義詞:

Cellular Fractionation Kit

登入查看組織和合約定價


About This Item

分類程式碼代碼:
41106500
暫時無法取得訂價和供貨情況

用途

sufficient for 100 extractions

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
avoid repeated freeze/thaw cycles

技術

DNA extraction: suitable
RNA extraction: suitable
nuclear extraction: suitable
protein extraction: suitable

輸入

sample type cells

運輸包裝

dry ice

儲存溫度

−20°C

一般說明

注意:1个测试=处理5 x 107细胞所需的足够试剂。
该试剂盒提供了独特的试剂组合,可用于从细胞质中分离出高度富集的线粒体级分。富集的级分可用于通过蛋白质印迹、ELISA或其他测定法研究目标因子。

成分

线粒体提取缓冲液、细胞液提取缓冲液、蛋白酶抑制剂混合物、还原试剂和用户操作步骤。

警告

毒性:多个毒性值,请参阅MSDS(O)

原則

ProteoExtract 细胞液/线粒体分级分离试剂盒设计用于哺乳动物细胞,以提取丰富的线粒体和胞质级分,从而用于下游分析,如蛋白质印迹。

準備報告

• 蛋白酶抑制剂混合物: 通过添加250 µlDMSO重溶冻干的蛋白酶抑制剂混合物;使用前要充分混合。分装成小份并储存在-20°C。•1X细胞液提取缓冲液混合物:通过用ddH2O以1:4的比例稀释细胞液提取缓冲液制备1X细胞液提取缓冲液。仅准备测定所需的量(5 x 107 细胞需要1 ml 1X 细胞液提取缓冲液混合物)。在使用前添加2 µl蛋白酶抑制剂混合物和1 µl DTT至1 ml 1X 细胞液提取缓冲液中。•线粒体提取缓冲液混合物:仅准备测定所需的量(5 x 107 细胞需要100 µl 线粒体提取缓冲液混合物)。在使用前添加2 µl蛋白酶抑制剂混合物和1 µl DTT至1 ml线粒体提取缓冲液中。

儲存和穩定性

收到货后将试剂盒的全部内容物存放在-20°C。初次使用后,将缓冲液存储在4°C,将DTT和蛋白酶抑制剂混合物存储在-20°C。

其他說明

由于该运输中有害物质的性质,您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系,以获取有关这些费用的更多信息。

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
PROTEOEXTRACT is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

CorrosionExclamation mark

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1B

儲存類別代碼

8A - Combustible corrosive hazardous materials


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Jung-Da Fang et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(3), 4327-4340 (2018-12-20)
Knockdown of the suppression of tumorigenicity 14-encoding type II transmembrane serine protease matriptase (MTP) in neural stem/progenitor (NS/P) cells impairs cell mobility, response to chemo-attractants, and neurovascular niche interaction. In the present study, we showed by Western blot that a
Jing Wang et al.
International journal of oncology, 51(2), 563-572 (2017-06-07)
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Despite improved remission rates, current treatment regimens for AML are often associated with a very poor prognosis and adverse effects, necessitating more effective and safer agents. B-cell leukemia/lymphoma 2
Hao Lu et al.
BMC veterinary research, 9, 217-217 (2013-10-24)
Locoweeds cause significant livestock poisoning and economic loss all over the world. Animals can develop locoism, a chronic neurological disease, after grazing on locoweeds. Oxytropis kansuensis is a variety of locoweed that contains swainsonine as its main toxic ingredient. The
Qiuyun Luo et al.
Oncology research, 28(4), 331-344 (2020-02-26)
Despite therapeutic advances, the effective treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) remains a major clinical challenge. Evasion of apoptosis through upregulating antiapoptotic B-cell lymphoma-2 (BCL-2) family members and p53 inactivation, and abnormal activation of B-cell receptor
Ga Bin Park et al.
Journal of immunology (Baltimore, Md. : 1950), 185(12), 7274-7284 (2010-11-17)
CD70 is expressed in normal activated immune cells as well as in several types of tumors. It has been established that anti-CD70 mAb induces complement-dependent death of CD70(+) tumor cells, but how anti-CD70 mAb affects the intrinsic signaling is poorly

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務